Unknown OBSERVATIONAL NCT04989062

Predicting Obesity Consequences Using Body Measure and Urine Metabolomics

Sponsor: Chang Gung Memorial Hospital

Conditions Body Composition Electric Impedance Non-Alcoholic Fatty Liver Disease

Interventions Bioelectrical impedance analysis Fibroscan Hand grip strength Urine unclear magnetic resonance metabolomics

Updated 5 times since 2021 Last updated: Jul 24, 2021 Started: Aug 1, 2020 Primary completion: Jul 31, 2022 Completion: Jul 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04989062, this observational or N/A phase trial focuses on Body Composition and Electric Impedance and remains ongoing. Sponsored by Chang Gung Memorial Hospital, it has been updated 5 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Aug 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Dec 2021 — Aug 2023 [monthly]

Recruiting
Sep 2021 — Dec 2021 [monthly]

Recruiting

First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chang Gung Memorial Hospital
Ministry of Science and Technology, Taiwan

Data source: Chang Gung Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chiayi City, Taiwan